United States PARP Inhibitors Market Report 2016

November 2016 | 103 pages | ID: U0450308833EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of PARP Inhibitors

Revenue, means the sales value of PARP Inhibitors

This report studies sales (consumption) of PARP Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• AstraZeneca PLC
• AbbVie Inc
• Clovis Oncology, Inc
• Medivation, Inc
• Tesaro, Inc.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of PARP Inhibitors in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States PARP Inhibitors Market Report 2016

1 PARP INHIBITORS OVERVIEW

1.1 Product Overview and Scope of PARP Inhibitors
1.2 Classification of PARP Inhibitors
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of PARP Inhibitors
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of PARP Inhibitors (2011-2021)
  1.4.1 United States PARP Inhibitors Sales and Growth Rate (2011-2021)
  1.4.2 United States PARP Inhibitors Revenue and Growth Rate (2011-2021)

2 UNITED STATES PARP INHIBITORS COMPETITION BY MANUFACTURERS

2.1 United States PARP Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States PARP Inhibitors Revenue and Share by Manufactures (2015 and 2016)
2.3 United States PARP Inhibitors Average Price by Manufactures (2015 and 2016)
2.4 PARP Inhibitors Market Competitive Situation and Trends
  2.4.1 PARP Inhibitors Market Concentration Rate
  2.4.2 PARP Inhibitors Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PARP INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States PARP Inhibitors Sales and Market Share by Type (2011-2016)
3.2 United States PARP Inhibitors Revenue and Market Share by Type (2011-2016)
3.3 United States PARP Inhibitors Price by Type (2011-2016)
3.4 United States PARP Inhibitors Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PARP INHIBITORS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States PARP Inhibitors Sales and Market Share by Application (2011-2016)
4.2 United States PARP Inhibitors Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PARP INHIBITORS MANUFACTURERS PROFILES/ANALYSIS

5.1 AstraZeneca PLC
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 PARP Inhibitors Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 AstraZeneca PLC PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AbbVie Inc
  5.2.2 PARP Inhibitors Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AbbVie Inc PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Clovis Oncology, Inc
  5.3.2 PARP Inhibitors Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Clovis Oncology, Inc PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Medivation, Inc
  5.4.2 PARP Inhibitors Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Medivation, Inc PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Tesaro, Inc.
  5.5.2 PARP Inhibitors Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Tesaro, Inc. PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview

6 PARP INHIBITORS MANUFACTURING COST ANALYSIS

6.1 PARP Inhibitors Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of PARP Inhibitors

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 PARP Inhibitors Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of PARP Inhibitors Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PARP INHIBITORS MARKET FORECAST (2016-2021)

10.1 United States PARP Inhibitors Sales, Revenue Forecast (2016-2021)
10.2 United States PARP Inhibitors Sales Forecast by Type (2016-2021)
10.3 United States PARP Inhibitors Sales Forecast by Application (2016-2021)
10.4 PARP Inhibitors Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of PARP Inhibitors
Table Classification of PARP Inhibitors
Figure United States Sales Market Share of PARP Inhibitors by Type in 2015
Table Application of PARP Inhibitors
Figure United States Sales Market Share of PARP Inhibitors by Application in 2015
Figure United States PARP Inhibitors Sales and Growth Rate (2011-2021)
Figure United States PARP Inhibitors Revenue and Growth Rate (2011-2021)
Table United States PARP Inhibitors Sales of Key Manufacturers (2015 and 2016)
Table United States PARP Inhibitors Sales Share by Manufacturers (2015 and 2016)
Figure 2015 PARP Inhibitors Sales Share by Manufacturers
Figure 2016 PARP Inhibitors Sales Share by Manufacturers
Table United States PARP Inhibitors Revenue by Manufacturers (2015 and 2016)
Table United States PARP Inhibitors Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States PARP Inhibitors Revenue Share by Manufacturers
Table 2016 United States PARP Inhibitors Revenue Share by Manufacturers
Table United States Market PARP Inhibitors Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market PARP Inhibitors Average Price of Key Manufacturers in 2015
Figure PARP Inhibitors Market Share of Top 3 Manufacturers
Figure PARP Inhibitors Market Share of Top 5 Manufacturers
Table United States PARP Inhibitors Sales by Type (2011-2016)
Table United States PARP Inhibitors Sales Share by Type (2011-2016)
Figure United States PARP Inhibitors Sales Market Share by Type in 2015
Table United States PARP Inhibitors Revenue and Market Share by Type (2011-2016)
Table United States PARP Inhibitors Revenue Share by Type (2011-2016)
Figure Revenue Market Share of PARP Inhibitors by Type (2011-2016)
Table United States PARP Inhibitors Price by Type (2011-2016)
Figure United States PARP Inhibitors Sales Growth Rate by Type (2011-2016)
Table United States PARP Inhibitors Sales by Application (2011-2016)
Table United States PARP Inhibitors Sales Market Share by Application (2011-2016)
Figure United States PARP Inhibitors Sales Market Share by Application in 2015
Table United States PARP Inhibitors Sales Growth Rate by Application (2011-2016)
Figure United States PARP Inhibitors Sales Growth Rate by Application (2011-2016)
Table AstraZeneca PLC Basic Information List
Table AstraZeneca PLC PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca PLC PARP Inhibitors Sales Market Share (2011-2016)
Table AbbVie Inc Basic Information List
Table AbbVie Inc PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Inc PARP Inhibitors Sales Market Share (2011-2016)
Table Clovis Oncology, Inc Basic Information List
Table Clovis Oncology, Inc PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Clovis Oncology, Inc PARP Inhibitors Sales Market Share (2011-2016)
Table Medivation, Inc Basic Information List
Table Medivation, Inc PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medivation, Inc PARP Inhibitors Sales Market Share (2011-2016)
Table Tesaro, Inc. Basic Information List
Table Tesaro, Inc. PARP Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tesaro, Inc. PARP Inhibitors Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PARP Inhibitors
Figure Manufacturing Process Analysis of PARP Inhibitors
Figure PARP Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of PARP Inhibitors Major Manufacturers in 2015
Table Major Buyers of PARP Inhibitors
Table Distributors/Traders List
Figure United States PARP Inhibitors Production and Growth Rate Forecast (2016-2021)
Figure United States PARP Inhibitors Revenue and Growth Rate Forecast (2016-2021)
Table United States PARP Inhibitors Production Forecast by Type (2016-2021)
Table United States PARP Inhibitors Consumption Forecast by Application (2016-2021 )